TickerFactsScreenerDevelopers

ENANTA PHARMACEUTICALS INC (ENTA) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2010: $466.0K2011: $6.84M2012: $10.51M2013: $8.86M2014: $30.70M2015: $21.73M2016: $16.58M2017: $65.67M2018: $63.90M2019: $51.23M2020: $87.13M2021: $57.21M2022: $43.99M2023: $85.39M2024: $37.23M2025: $32.30M$32.30M
2010Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$32.30M-13.3%
2024$37.23M-56.4%
2023$85.39M+94.1%
2022$43.99M-23.1%
2021$57.21M-34.3%
2020$87.13M+70.1%
2019$51.23M-19.8%
2018$63.90M-2.7%
2017$65.67M+296.2%
2016$16.58M-23.7%
2015$21.73M-29.2%
2014$30.70M+246.5%
2013$8.86M-15.7%
2012$10.51M+53.7%
2011$6.84M+1367.2%
2010$466.0K—